198 related articles for article (PubMed ID: 2572252)
1. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
[TBL] [Abstract][Full Text] [Related]
2. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the autonomic control of the failing heart.
Snow HM
Basic Res Cardiol; 1989; 84 Suppl 1():163-76. PubMed ID: 2573339
[TBL] [Abstract][Full Text] [Related]
4. Long-term studies with xamoterol in heart failure.
Waller DG
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
6. Focus on diastolic dysfunction: a new approach to heart failure therapy.
Pouleur H; Hanet C; Gurné O; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):41S-52S. PubMed ID: 2572254
[TBL] [Abstract][Full Text] [Related]
7. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Marlow HF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
[TBL] [Abstract][Full Text] [Related]
8. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
9. The management of heart failure and the scope for new therapies: what role for xamoterol?
Campbell RW
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):59S-64S. PubMed ID: 2572256
[TBL] [Abstract][Full Text] [Related]
10. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
11. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic modulation in practice: the German clinical experience.
Kupper W; Erlemeier HH; Bleifeld W
Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
[TBL] [Abstract][Full Text] [Related]
13. Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
Furlong R; Brogden RN
Drugs; 1988 Oct; 36(4):455-74. PubMed ID: 2906865
[TBL] [Abstract][Full Text] [Related]
14. The effect of xamoterol in failing human myocardium.
Schwinger RH; Böhm M; Erdmann E
Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of ICI 118,587, a new beta-adrenoceptor partial agonist in man.
Sasayama S; Yokawa S; Akiyama M; Mikawa M; Sakai O
Jpn Circ J; 1986 Jul; 50(7):636-43. PubMed ID: 2877103
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist.
Detry JM; Decoster PM; Brasseur LA
Eur Heart J; 1983 Aug; 4(8):584-91. PubMed ID: 6139282
[TBL] [Abstract][Full Text] [Related]
17. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
20. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
van Mechelen H; Ries A; Pouleur H; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
